Scrip: industry news and insights
First-Line Bavencio Bladder Cancer OK Boosts Merck KGaA
By Kevin Grogan 25 Jan 2021
Pfizer-partnered Bavencio has struggled to compete with other checkpoint inhibitors like Keytruda, Opdivo, Imfinzi and Tecentriq, but could carve out...